Natixis Advisors LLC Has $16.34 Million Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Natixis Advisors LLC increased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1,335.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 209,246 shares of the company’s stock after buying an additional 194,665 shares during the period. Natixis Advisors LLC owned 0.42% of Prestige Consumer Healthcare worth $16,340,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Raymond James Financial Inc. bought a new position in Prestige Consumer Healthcare in the 4th quarter valued at about $42,593,000. Boston Trust Walden Corp lifted its position in Prestige Consumer Healthcare by 43.5% in the 4th quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock valued at $64,942,000 after acquiring an additional 252,089 shares in the last quarter. Wellington Management Group LLP bought a new position in Prestige Consumer Healthcare in the 3rd quarter valued at about $6,342,000. Great Lakes Advisors LLC lifted its position in Prestige Consumer Healthcare by 113.7% in the 4th quarter. Great Lakes Advisors LLC now owns 139,116 shares of the company’s stock valued at $10,864,000 after acquiring an additional 74,016 shares in the last quarter. Finally, Barclays PLC lifted its position in Prestige Consumer Healthcare by 346.3% in the 3rd quarter. Barclays PLC now owns 92,444 shares of the company’s stock valued at $6,665,000 after acquiring an additional 71,730 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock opened at $84.01 on Wednesday. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The stock has a market cap of $4.16 billion, a P/E ratio of 19.67, a P/E/G ratio of 2.69 and a beta of 0.46. The company’s 50 day moving average price is $81.87 and its two-hundred day moving average price is $78.45. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently weighed in on PBH shares. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Oppenheimer raised their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. DA Davidson lifted their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Sidoti cut shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price on the stock. in a research report on Monday, December 9th. Finally, Canaccord Genuity Group lifted their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $92.60.

Insider Transactions at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. This represents a 8.91 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.